Daniel P Poole Selected Research

Daniel P Poole Research Topics

Disease

20	Pain (Aches) 01/2022 - 09/2009
17	Inflammation (Inflammations) 01/2022 - 10/2007
6	Colitis 01/2022 - 08/2015
5	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022 - 08/2015
5	Hyperalgesia 01/2022 - 09/2009
5	Neurogenic Inflammation 01/2020 - 07/2008
4	Constipation 01/2022 - 01/2013
4	Chronic Pain 01/2022 - 01/2015
3	Diarrhea 01/2022 - 01/2013
3	Hypersensitivity (Allergy) 01/2020 - 08/2015
2	Arthritis (Polyarthritis) 01/2022 - 01/2017
2	Edema (Dropsy) 01/2021 - 01/2020
2	Chronic Disease (Chronic Diseases) 01/2020 - 01/2017
2	Pruritus (Itching) 12/2014 - 04/2013
1	Pulmonary Edema 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Legionnaires' Disease (Legionnaire's Disease) 01/2019
1	Mouth Neoplasms (Oral Cancer) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Infections 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 10/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Malaria 01/2017
1	Cough 01/2015

Drug/Important Bio-Agent (IBA)

8	Ion Channels (Ion Channel)IBA 01/2021 - 07/2008
7	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 02/2013
6	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2022 - 05/2014
6	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 02/2013
6	Opioid Analgesics (Opioids)IBA 01/2020 - 04/2013
4	PAR-2 ReceptorIBA 01/2022 - 09/2009
4	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2022 - 08/2019
4	Substance PIBA 12/2019 - 05/2014
4	Bile Acids and Salts (Bile Acids)IBA 12/2014 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2019
2	CytokinesIBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2007
2	Aprepitant (Emend)FDA Link 01/2022 - 12/2019
2	Neurokinin-1 Receptor AntagonistsIBA 01/2022 - 01/2021
2	ArrestinIBA 01/2022 - 02/2013
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020 - 08/2019
2	Irritants (Vesicants)IBA 10/2019 - 01/2015
2	Serine Proteases (Serine Protease)IBA 01/2019 - 09/2009
2	Capsaicin (Zostrix)FDA Link 11/2017 - 07/2008
2	Transient Receptor Potential ChannelsIBA 08/2015 - 01/2015
2	AnkyrinsIBA 12/2014 - 08/2011
2	NeuropeptidesIBA 02/2013 - 12/2009
2	Protein Kinase CIBA 09/2009 - 10/2007
1	AminesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	PolymersIBA 01/2022
1	Castor Oil (Oil, Castor)IBA 01/2022
1	Proteinase-Activated ReceptorsIBA 01/2022
1	Dynamin IIIBA 01/2022
1	BMS-986187IBA 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	LipidsIBA 01/2021
1	Thrombin FDA Link 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	eluxadolineIBA 01/2020
1	Tissue ExtractsIBA 01/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Dextran SulfateIBA 10/2018
1	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 10/2018
1	TrypsinIBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	ClathrinIBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	cathepsin SIBA 01/2018
1	ivacaftor drug combination lumacaftorIBA 01/2018
1	ivacaftorIBA 01/2018
1	Formaldehyde (Formol)FDA Link 11/2017
1	calcitonin gene-related peptide (8-37)IBA 11/2017
1	Calcitonin Gene-Related PeptideIBA 11/2017
1	Calcitonin Receptor-Like ProteinIBA 11/2017
1	Freund's AdjuvantIBA 11/2017
1	Cell Surface ReceptorsIBA 01/2017
1	ZymosanIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017
1	CRT 0066101IBA 05/2016
1	Interleukin-10 (Interleukin 10)IBA 08/2015
1	Piroxicam (Feldene)FDA LinkGeneric 08/2015
1	Trinitrobenzenesulfonic AcidIBA 08/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2015
1	5,6-epoxy-8,11,14-eicosatrienoic acidIBA 08/2015
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2015

Therapy/Procedure

5	Therapeutics 01/2020 - 09/2010
2	Spinal Injections 12/2019 - 08/2015
1	Injections 08/2015